1. Adlere I, Sun S, Zarca A, Roumen L, Gozelle M, Viciano CP, Caspar B, Arimont M, Bebelman JP, Briddon SJ et al.. (2019) Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists.
Eur J Med Chem, 162: 631-649.
DOI: 10.1016/j.ejmech.2018.10.060
[PMID:30476826]
2. Albright AV, Shieh JT, Itoh T, Lee B, Pleasure D, O'Connor MJ, Doms RW, González-Scarano F. (1999) Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates.
J. Virol., 73 (1): 205-13.
[PMID:9847323]
3. Anton PA, Elliott J, Poles MA, McGowan IM, Matud J, Hultin LE, Grovit-Ferbas K, Mackay CR, Chen ISY, Giorgi JV. (2000) Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue.
AIDS, 14 (12): 1761-5.
[PMID:10985313]
4. Ayehunie S, Garcia-Zepeda EA, Hoxie JA, Horuk R, Kupper TS, Luster AD, Ruprecht RM. (1997) Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors.
Blood, 90 (4): 1379-86.
[PMID:9269754]
5. Balabanian K, Lagane B, Pablos JL, Laurent L, Planchenault T, Verola O, Lebbe C, Kerob D, Dupuy A, Hermine O et al.. (2005) WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.
Blood, 105 (6): 2449-57.
[PMID:15536153]
6. Banisadr G, Dicou E, Berbar T, Rostène W, Lombet A, Haour F. (2000) Characterization and visualization of [125I] stromal cell-derived factor-1alpha binding to CXCR4 receptors in rat brain and human neuroblastoma cells.
J. Neuroimmunol., 110 (1-2): 151-60.
[PMID:11024545]
7. Belmadani A, Tran PB, Ren D, Assimacopoulos S, Grove EA, Miller RJ. (2005) The chemokine stromal cell-derived factor-1 regulates the migration of sensory neuron progenitors.
J. Neurosci., 25 (16): 3995-4003.
[PMID:15843601]
8. Berson JF, Long D, Doranz BJ, Rucker J, Jirik FR, Doms RW. (1996) A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
J. Virol., 70 (9): 6288-95.
[PMID:8709256]
9. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA. (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry.
Nature, 382 (6594): 829-33.
[PMID:8752280]
10. Burger JA, Kipps TJ. (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.
Blood, 107 (5): 1761-7.
[PMID:16269611]
11. Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, Arenzana-Seisdedos F, Virelizier JL, Baggiolini M, Sykes BD, Clark-Lewis I. (1997) Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.
EMBO J., 16 (23): 6996-7007.
[PMID:9384579]
12. Deichmann M, Kronenwett R, Haas R. (1997) Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34+ hematopoietic progenitor cells.
Blood, 89 (10): 3522-8.
[PMID:9160656]
13. Delézay O, Koch N, Yahi N, Hammache D, Tourres C, Tamalet C, Fantini J. (1997) Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29.
AIDS, 11 (11): 1311-8.
[PMID:9302439]
14. Di Salvo J, Koch GE, Johnson KE, Blake AD, Daugherty BL, DeMartino JA, Sirotina-Meisher A, Liu Y, Springer MS, Cascieri MA et al.. (2000) The CXCR4 agonist ligand stromal derived factor-1 maintains high affinity for receptors in both Galpha(i)-coupled and uncoupled states.
Eur. J. Pharmacol., 409 (2): 143-54.
[PMID:11104827]
15. Drury LJ, Ziarek JJ, Gravel S, Veldkamp CT, Takekoshi T, Hwang ST, Heveker N, Volkman BF, Dwinell MB. (2011) Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways.
Proc. Natl. Acad. Sci. U.S.A., 108 (43): 17655-60.
[PMID:21990345]
16. Feng Y, Broder CC, Kennedy PE, Berger EA. (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.
Science, 272 (5263): 872-7.
[PMID:8629022]
17. Flynn G, Maru S, Loughlin J, Romero IA, Male D. (2003) Regulation of chemokine receptor expression in human microglia and astrocytes.
J. Neuroimmunol., 136 (1-2): 84-93.
[PMID:12620646]
18. Foley M, Pow A, Griffiths K, Cobb S, Viduka K. (2016) Cxcr4 binding molecules.
Patent number: WO2016109872. Assignee: Adalta Pty Ltd. Priority date: 09/01/2015. Publication date: 14/07/2016.
19. Fricker SP, Anastassov V, Cox J, Darkes MC, Grujic O, Idzan SR, Labrecque J, Lau G, Mosi RM, Nelson KL et al.. (2006) Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4.
Biochem. Pharmacol., 72 (5): 588-96.
[PMID:16815309]
20. Gouwy M, Struyf S, Catusse J, Proost P, Van Damme J. (2004) Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.
J. Leukoc. Biol., 76 (1): 185-94.
[PMID:15075362]
21. Gupta SK, Pillarisetti K. (1999) Cutting edge: CXCR4-Lo: molecular cloning and functional expression of a novel human CXCR4 splice variant.
J. Immunol., 163 (5): 2368-72.
[PMID:10452968]
22. Habasque C, Aubry F, Jégou B, Samson M. (2002) Study of the HIV-1 receptors CD4, CXCR4, CCR5 and CCR3 in the human and rat testis.
Mol. Hum. Reprod., 8 (5): 419-25.
[PMID:11994538]
23. Heesen M, Berman MA, Benson JD, Gerard C, Dorf ME. (1996) Cloning of the mouse fusin gene, homologue to a human HIV-1 co-factor.
J. Immunol., 157 (12): 5455-60.
[PMID:8955194]
24. Heesen M, Berman MA, Höpken UE, Gerard NP, Dorf ME. (1997) Alternate splicing of mouse fusin/CXC chemokine receptor-4: stromal cell-derived factor-1alpha is a ligand for both CXC chemokine receptor-4 isoforms.
J. Immunol., 158 (8): 3561-4.
[PMID:9103415]
25. Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, Francois F, Klotman ME, Diaz GA. (2003) Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.
Nat. Genet., 34 (1): 70-4.
[PMID:12692554]
26. Hesselgesser J, Liang M, Hoxie J, Greenberg M, Brass LF, Orsini MJ, Taub D, Horuk R. (1998) Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity.
J. Immunol., 160 (2): 877-83.
[PMID:9551924]
27. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. (2006) Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors.
Stem Cells, 24 (4): 1030-41.
[PMID:16253981]
28. Huber TB, Reinhardt HC, Exner M, Burger JA, Kerjaschki D, Saleem MA, Pavenstädt H. (2002) Expression of functional CCR and CXCR chemokine receptors in podocytes.
J. Immunol., 168 (12): 6244-52.
[PMID:12055238]
29. Hunter ZR, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Manning RJ, Tripsas C, Patterson CJ, Sheehy P et al.. (2014) The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.
Blood, 123 (11): 1637-46.
[PMID:24366360]
30. Iikura M, Miyamasu M, Yamaguchi M, Kawasaki H, Matsushima K, Kitaura M, Morita Y, Yoshie O, Yamamoto K, Hirai K. (2001) Chemokine receptors in human basophils: inducible expression of functional CXCR4.
J Leukoc Biol, 70: 113-120.
[PMID:11435493]
31. Inngjerdingen M, Damaj B, Maghazachi AA. (2001) Expression and regulation of chemokine receptors in human natural killer cells.
Blood, 97 (2): 367-75.
[PMID:11154210]
32. Jiang Y, Salafranca MN, Adhikari S, Xia Y, Feng L, Sonntag MK, deFiebre CM, Pennell NA, Streit WJ, Harrison JK. (1998) Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis.
J. Neuroimmunol., 86 (1): 1-12.
[PMID:9655467]
33. Jordan NJ, Kolios G, Abbot SE, Sinai MA, Thompson DA, Petraki K, Westwick J. (1999) Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells.
J. Clin. Invest., 104 (8): 1061-9.
[PMID:10525044]
34. Kitchen SG, Zack JA. (1997) CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus.
J. Virol., 71 (9): 6928-34.
[PMID:9261420]
35. Kledal TN, Rosenkilde MM, Coulin F, Simmons G, Johnsen AH, Alouani S, Power CA, Lüttichau HR, Gerstoft J, Clapham PR et al.. (1997) A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.
Science, 277 (5332): 1656-9.
[PMID:9287217]
36. Kowalska MA, Ratajczak J, Hoxie J, Brass LF, Gewirtz A, Poncz M, Ratajczak MZ. (1999) Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets.
Br. J. Haematol., 104 (2): 220-9.
[PMID:10050701]
37. Kuhne M, Brams P,Tanamachi DM,Korman AJ, Cardarelli JM. (2013) Human monoclonal antibodies that bind CXCR4.
Patent number: US8450464 B2. Assignee: Medarex, Inc.. Priority date: 02/10/2006. Publication date: 28/05/2013.
38. Lagane B, Chow KY, Balabanian K, Levoye A, Harriague J, Planchenault T, Baleux F, Gunera-Saad N, Arenzana-Seisdedos F, Bachelerie F. (2008) CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome.
Blood, 112 (1): 34-44.
[PMID:18436740]
39. Larochelle A, Krouse A, Metzger M, Orlic D, Donahue RE, Fricker S, Bridger G, Dunbar CE, Hematti P. (2006) AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
Blood, 107 (9): 3772-8.
[PMID:16439684]
40. Liu X, Mao J, Han C, Peng S, Li C, Jin T, Fan C, Shan Z, Teng W. (2016) CXCR4 antagonist AMD3100 ameliorates thyroid damage in autoimmune thyroiditis in NOD.H‑2h⁴ mice.
Mol Med Rep, 13 (4): 3604-12.
[PMID:26935473]
41. Loetscher M, Geiser T, O'Reilly T, Zwahlen R, Baggiolini M, Moser B. (1994) Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes.
J. Biol. Chem., 269 (1): 232-7.
[PMID:8276799]
42. Loetscher P, Gong JH, Dewald B, Baggiolini M, Clark-Lewis I. (1998) N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities.
J. Biol. Chem., 273 (35): 22279-83.
[PMID:9712844]
43. Lu M, Grove EA, Miller RJ. (2002) Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor.
Proc. Natl. Acad. Sci. U.S.A., 99 (10): 7090-5.
[PMID:11983855]
44. McDermott DH, Gao JL, Liu Q, Siwicki M, Martens C, Jacobs P, Velez D, Yim E, Bryke CR, Hsu N et al.. (2015) Chromothriptic cure of WHIM syndrome.
Cell, 160 (4): 686-99.
[PMID:25662009]
45. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ. (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity.
Proc. Natl. Acad. Sci. U.S.A., 95 (24): 14500-5.
[PMID:9826729]
46. Miller EJ, Jecs E, Truax VM, Katzman BM, Tahirovic YA, Wilson RJ, Kuo KM, Kim MB, Nguyen HH, Saindane MT et al.. (2018) Discovery of Tetrahydroisoquinoline-Containing CXCR4 Antagonists with Improved in Vitro ADMET Properties.
J. Med. Chem., 61 (3): 946-979.
[PMID:29350534]
47. Moepps B, Frodl R, Rodewald HR, Baggiolini M, Gierschik P. (1997) Two murine homologues of the human chemokine receptor CXCR4 mediating stromal cell-derived factor 1alpha activation of Gi2 are differentially expressed in vivo.
Eur. J. Immunol., 27 (8): 2102-12.
[PMID:9295051]
48. Molyneaux KA, Zinszner H, Kunwar PS, Schaible K, Stebler J, Sunshine MJ, O'Brien W, Raz E, Littman D, Wylie C et al.. (2003) The chemokine SDF1/CXCL12 and its receptor CXCR4 regulate mouse germ cell migration and survival.
Development, 130 (18): 4279-86.
[PMID:12900445]
49. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF et al.. (1996) The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.
Nature, 382 (6594): 833-5.
[PMID:8752281]
50. Oh SB, Endoh T, Simen AA, Ren D, Miller RJ. (2002) Regulation of calcium currents by chemokines and their receptors.
J. Neuroimmunol., 123 (1-2): 66-75.
[PMID:11880151]
51. Pozzobon T, Goldoni G, Viola A, Molon B. (2016) CXCR4 signaling in health and disease.
Immunol. Lett., 177: 6-15.
[PMID:27363619]
52. Randhawa S, Cho BS, Ghosh D, Sivina M, Koehrer S, Müschen M, Peled A, Davis RE, Konopleva M, Burger JA. (2016) Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemia.
Br. J. Haematol., 174 (3): 425-36.
[PMID:27071778]
53. Rueda P, Balabanian K, Lagane B, Staropoli I, Chow K, Levoye A, Laguri C, Sadir R, Delaunay T, Izquierdo E et al.. (2008) The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins.
PLoS ONE, 3 (7): e2543.
[PMID:18648536]
54. Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ. (1999) Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.
Am. J. Pathol., 154 (4): 1125-35.
[PMID:10233851]
55. Scala S. (2015) Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment.
Clin. Cancer Res., 21 (19): 4278-85.
[PMID:26199389]
56. Sehgal A, Ricks S, Boynton AL, Warrick J, Murphy GP. (1998) Molecular characterization of CXCR-4: a potential brain tumor-associated gene.
J Surg Oncol, 69 (4): 239-48.
[PMID:9881942]
57. Skerlj RT, Bridger GJ, Kaller A, McEachern EJ, Crawford JB, Zhou Y, Atsma B, Langille J, Nan S, Veale D et al.. (2010) Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication.
J. Med. Chem., 53 (8): 3376-88.
[PMID:20297846]
58. Stumm RK, Zhou C, Ara T, Lazarini F, Dubois-Dalcq M, Nagasawa T, Höllt V, Schulz S. (2003) CXCR4 regulates interneuron migration in the developing neocortex.
J. Neurosci., 23 (12): 5123-30.
[PMID:12832536]
59. Sun Y, Cheng Z, Ma L, Pei G. (2002) Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation.
J. Biol. Chem., 277 (51): 49212-9.
[PMID:12370187]
60. Tamamura H, Hiramatsu K, Mizumoto M, Ueda S, Kusano S, Terakubo S, Akamatsu M, Yamamoto N, Trent JO, Wang Z et al.. (2003) Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists.
Org. Biomol. Chem., 1 (21): 3663-9.
[PMID:14649897]
61. Tamamura H, Xu Y, Hattori T, Zhang X, Arakaki R, Kanbara K, Omagari A, Otaka A, Ibuka T, Yamamoto N et al.. (1998) A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140.
Biochem. Biophys. Res. Commun., 253 (3): 877-82.
[PMID:9918823]
62. Thoma G, Streiff MB, Kovarik J, Glickman F, Wagner T, Beerli C, Zerwes HG. (2008) Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo.
J. Med. Chem., 51 (24): 7915-20.
[PMID:19053768]
63. Walenkamp AME, Lapa C, Herrmann K, Wester HJ. (2017) CXCR4 Ligands: The Next Big Hit?.
J. Nucl. Med., 58 (Suppl 2): 77S-82S.
[PMID:28864616]
64. Wang Z, Sun J, Feng Y, Tian X, Wang B, Zhou Y. (2016) Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell.
Tumour Biol., 37 (7): 8515-28.
[PMID:27079871]
65. Wilson RJ, Jecs E, Miller EJ, Nguyen HH, Tahirovic YA, Truax VM, Kim MB, Kuo KM, Wang T, Sum CS et al.. (2018) Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 Antagonists.
ACS Med Chem Lett, 9 (1): 17-22.
[PMID:29348805]
66. Wong ML, Xin WW, Duman RS. (1996) Rat LCR1: cloning and cellular distribution of a putative chemokine receptor in brain.
Mol. Psychiatry, 1 (2): 133-40.
[PMID:9118323]
67. Wong RS, Bodart V, Metz M, Labrecque J, Bridger G, Fricker SP. (2008) Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors.
Mol. Pharmacol., 74 (6): 1485-95.
[PMID:18768385]
68. Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC et al.. (2010) Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.
Science, 330 (6007): 1066-71.
[PMID:20929726]
69. Wu KJ, Yu SJ, Shia KS, Wu CH, Song JS, Kuan HH, Yeh KC, Chen CT, Bae E, Wang Y. (2017) A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain.
Cell Transplant, 26 (4): 571-583.
[PMID:27938478]
70. Yu L, Cecil J, Peng SB, Schrementi J, Kovacevic S, Paul D, Su EW, Wang J. (2006) Identification and expression of novel isoforms of human stromal cell-derived factor 1.
Gene, 374: 174-9.
[PMID:16626895]
71. Zamarchi R, Allavena P, Borsetti A, Stievano L, Tosello V, Marcato N, Esposito G, Roni V, Paganin C, Bianchi G et al.. (2002) Expression and functional activity of CXCR-4 and CCR-5 chemokine receptors in human thymocytes.
Clin. Exp. Immunol., 127 (2): 321-30.
[PMID:11876757]
72. Zhang H, Kang D, Huang B, Liu N, Zhao F, Zhan P, Liu X. (2016) Discovery of non-peptide small molecular CXCR4 antagonists as anti-HIV agents: Recent advances and future opportunities.
Eur J Med Chem, 114: 65-78.
[PMID:26974376]
73. Zhang WB, Navenot JM, Haribabu B, Tamamura H, Hiramatu K, Omagari A, Pei G, Manfredi JP, Fujii N, Broach JR, Peiper SC. (2002) A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists.
J Biol Chem, 277: 24515-24521.
[PMID:11923301]
74. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development.
Nature, 393 (6685): 595-9.
[PMID:9634238]